my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
09-07-2012: Calixar and Synthelis announced that they have entered into an alliance for the production and isolation of all types of target membrane proteins. The results of this collaboration will have applications ranging from the development of antibodies to the discovery of new drugs, including the determination of the structure of these targets and vaccine formulations.
Instead of trying to produce these proteins themselves, users will be given access to state-of-the-art production and purification technologies, enabling them to concentrate on their core activities. Furthermore, thanks to the critical mass of skills and technologies made available to them, they will be assured of obtaining targets in their native conformation, thus guaranteeing the success of their programs for developing new drugs, vaccines and therapeutic antibodies.
Watchlist
This is where you can add this news to your personal favourites
Calixar and Synthelis team up to provide unique membrane protein services
Calixar and Synthelis announced that they have entered into an alliance for the production and isolation of all types of target membrane proteins. The results of this collaboration will have applications ranging from the development of antibodies to the discovery of new drugs, including the ... more
Calixar closes an initial EUR 875,000 funding round
Calixar SAS, a start-up providing services focused on membrane proteins, announces that it has completed an initial funding round in which it raised EUR 875,000 from private investors and business angels. The investors that took part in this financing were Siparex, Veymont Participations, I ... more
Calixar and Synthelis team up to provide unique membrane protein services
Calixar and Synthelis announced that they have entered into an alliance for the production and isolation of all types of target membrane proteins. The results of this collaboration will have applications ranging from the development of antibodies to the discovery of new drugs, including the ... more
Über CHEMIE.DE
CHEMIE.DE Information Service GmbH runs specialist scientific internet portals. The secret to our success? We are familiar with what we publish.
Advertising at CHEMIE.DE
Our advertising formats support you in getting your message across to a clearly defined target audience.
© 1997-2013 CHEMIE.DE Information Service GmbH, All rights reserved
Netmeeting
